Gregory S. Moss

CIK: 0001742496

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (11.1%)

Position reduction

Option Exercises (M)2 (22.2%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AVR

Anteris Technologies Global Corp.

Director

EVMN

Evommune, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

AVR
Anteris Technologies Global Corp.
Jun 7, 2026
Exercise(M)
Direct
17.6K shares-
EVMN
Evommune, Inc.
May 28, 2026
Exercise(M)
Direct
14.2K shares at avg. $1.71$24K
EVMN
Evommune, Inc.
May 28, 2026
Sale(S)
Direct
14.2K shares at avg. $22.83$325K
EVMN
Evommune, Inc.
Apr 16, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
115.3K shares-
EVMN
Evommune, Inc.
Dec 9, 2025
Tax Payment(F)
Direct
13.6K shares at avg. $17.84$243K
AVR
Anteris Technologies Global Corp.
Dec 3, 2025
Award(A)
Restricted Stock Units
Direct
52.7K shares-
AVR
Anteris Technologies Global Corp.
Dec 3, 2025
Award(A)
Restricted Stock Units
Direct
13.8K shares-
EVMN
Evommune, Inc.
Nov 7, 2025
Conversion(C)
Indirect
3.2K shares-
EVMN
Evommune, Inc.
Nov 5, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
293.5K shares-

		Type	Shares	Price		Ownership
Jun 7, 2026	AVR Anteris Technologies Global Corp.	Exercise(M)	17,580	-	$0	Direct
May 28, 2026	EVMN Evommune, Inc.	Exercise(M)	14,223	$1.71	$24,321	Direct
May 28, 2026	EVMN Evommune, Inc.	Sale(S)	14,223	$22.83	$324,711	Direct
Apr 16, 2026	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	115,279	-	-	Direct
Dec 9, 2025	EVMN Evommune, Inc.	Tax Payment(F)	13,624	$17.84	$243,052	Direct
Dec 3, 2025	AVR Anteris Technologies Global Corp.	Award(A) Restricted Stock Units	52,742	-	-	Direct
Dec 3, 2025	AVR Anteris Technologies Global Corp.	Award(A) Restricted Stock Units	13,821	-	-	Direct
Nov 7, 2025	EVMN Evommune, Inc.	Conversion(C)	3,175	-	-	Indirect
Nov 5, 2025	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	293,496	-	-	Direct

1-9 of 9 transactions

About Moss Gregory S.

Moss Gregory S. (SEC CIK 0001742496) files insider reports with the SEC as Director of Anteris Technologies Global Corp. (AVR) and Chief Business & Legal Officer of Evommune, Inc. (EVMN).

Signal8 holds 9 ownership filings by Moss Gregory S. (2 Form 3, 7 Form 4), filed between Jun 10, 2025 and Jun 9, 2026. Those filings report 9 transactions, from Nov 5, 2025 to Jun 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Moss Gregory S.'s filings is in PALO ALTO, CA.

Recent filings by Moss Gregory S.

Jun 7, 2026: Option exercise of AVR shares (Form 4, code M).
May 28, 2026: Option exercise of EVMN shares (Form 4, code M).
May 28, 2026: Open-market sale of EVMN shares (Form 4, code S).
Apr 16, 2026: Grant or award of EVMN derivative securities (Form 4, code A).
Dec 9, 2025: Tax withholding of EVMN shares (Form 4, code F).

Other insiders filing for Anteris Technologies Global Corp. (AVR)

L1 Capital Pty Ltd, 10% Owner
Moen Brent, Chief Financial Officer
St Denis David, Chief Operating Officer
Roberts David B, Director
McDonnell Matthew, Chief Financial Officer
Knight Susan Elizabeth, Director

How to read Form 4 transaction codes